SinoMab BioScience Limited (HKG:3681)
Hong Kong
· Delayed Price · Currency is HKD 1.930
+0.030 (1.58%)
At close: Mar 10, 2026
SinoMab BioScience Market Cap
SinoMab BioScience has a market cap or net worth of 2.68 billion as of March 10, 2026. Its market cap has increased by 122.84% in one year.
Market Cap
2.68B
Enterprise Value
2.97B
Revenue
6.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.93
Market Cap Chart
Since November 12, 2019, SinoMab BioScience's market cap has decreased from 6.04B to 2.68B, a decrease of -55.67%. That is a compound annual growth rate of -12.07%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Antengene Corporation | 2.66B |
| Jiangsu Recbio Technology | 2.65B |
| Clover Biopharmaceuticals | 2.51B |
| BioDlink International Company | 3.11B |
| Medtide | 3.20B |
| Frontage Holdings | 2.23B |
| AIM Vaccine | 3.61B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.98B |